"Drug development can be time-consuming and expensive. Recent estimates suggest that, on average, it takes 10 years and at least $1 billion to bring a drug to market. Given the time and expense of developing drugs de novo, pharmaceutical companies have become increasingly interested in finding new uses for existing drugs--a process referred to as drug repurposing or repositioning. Historically, drug repurposing has been largely an unintentional, serendipitous process that took place when a drug was found to have an offtarget effect or a previously unrecognized on-target effect that could be used for identifying a new indication. Perhaps the most recognizable example of such a successful repositioning effort is sildenafil. Originally developed as an anti-hypertensive, sildenafil, marketed as Viagra and under other trade names, has been repurposed for the treatment of erectile dysfunction and pulmonary arterial hypertension. Viagra gener
ISBN: | 9780309302043 |
Publication date: | 8th August 2014 |
Author: | Drug Repurposing and Repositioning Workshop, Sarah H Beachy, Samuel G Johnson, Steve Olson, Adam C Berger, Institute of Medicine US |
Publisher: | National Academies Press an imprint of The National Academies Press |
Format: | Paperback |
Genres: |
Pharmaceutical chemistry and technology |